Reduced fractionation radiotherapy feasible for localised prostate cancer
Reduced fractionation radiotherapy feasible for localised prostate cancer
ASTRO 2015 highlights: UK perspective
Challenge of cancer in middle-income countries with an ageing population
Geonomic testing may help predict metastatic risk after prostatectomy and salvage radiotherapy
Conventional vs hypofractionated IMRT for localised prostate cancer
Deintensified chemoradiation for HPV-associated oropharyngeal cancer
Nurse-led head and neck cancer clinic helps reduce post-treatment symptoms, emergency visits and hospitalisations
Accelerated partial breast irradiation valid alternative to whole breast irradiation in early breast cancer
Image-guided IMRT reduces bowel effects in cervical cancer patients
Does photon radiation therapy reduce ear toxicity in children with medulloblastoma?
Patient-reported feedback improves outcomes of palliative radiation therapy and care
Radiological management of intermediate-risk meningioma
Managing late and ongoing effects of treatment in prostate cancer survivors
Dexamethasone can reduce radiation-induced pain flares
Combining immunotherapy with stereotactic body radiotherapy
Longer duration of ADT after radiotherapy improves disease-free survival in prostate cancer
Mobile app designed to help manage radiation therapy toxicities
Favourable results seen with radiotherapy for rare paediatric brain and spinal cord tumour
Systemic immunotherapy and radiotherapy combination shows promise in advanced skin cancer
Improving the consistency of radiation oncology processes
Is 3D-conformational or intensity-modulated radiation therapy better for NSCLC?
First ASTRO glioblastoma guidelines under review
Individualised stereotactic body radiotherapy of liver metastases
Care of patients receiving chemoradiation
ASTRO 2015: Technology meets patient care
Novel approaches to treating oligometastases
Economics of radiation therapy
Can early stage NSCLC be treated with stereotactic radiation therapy?
Stereotactic radiation therapy for oligmetastases
Can SBRT be of use for early, operable non-small cell lung cancer?
Investigating genetic vulnerabilities to radiation therapy
Raising the bar on radiation oncology excellence